We also note that this study primarily used hamsters to evaluate the immunogenicity and efficacy of our S2-based vaccine construct because hamsters are naturally susceptible to infection by SARS-CoV-2 without the requirement of virus adaptation or the need of human ACE2 expressing transgenic hamsters. This evidence concerns the gene ACE2 and infection.